Literature DB >> 6703502

The role of Mycobacterium xenopi in human disease.

A E Simor, I E Salit, H Vellend.   

Abstract

Mycobacterium xenopi is infrequently recognized as a cause of pulmonary infection. We isolated this organism from 28 patients over a 3-yr period. It was nonpathogenic in 19 and pathogenic in 9. Clinical illness occurred in middle-aged men with other chronic pulmonary diseases. Therapy was associated with clinical improvement, but most isolates were resistant to first-line antituberculosis drugs. The prevalence of M. xenopi varies geographically, but in the province of Ontario, it is second to M. avium-intracellulare as the most common nontuberculous mycobacterial pathogen.

Entities:  

Mesh:

Substances:

Year:  1984        PMID: 6703502     DOI: 10.1164/arrd.1984.129.3.435

Source DB:  PubMed          Journal:  Am Rev Respir Dis        ISSN: 0003-0805


  13 in total

Review 1.  Antimicrobial susceptibility testing, drug resistance mechanisms, and therapy of infections with nontuberculous mycobacteria.

Authors:  Barbara A Brown-Elliott; Kevin A Nash; Richard J Wallace
Journal:  Clin Microbiol Rev       Date:  2012-07       Impact factor: 26.132

Review 2.  Nontuberculous mycobacteria and the lung: from suspicion to treatment.

Authors:  Emmet E McGrath; Zoe Blades; Josie McCabe; Hannah Jarry; Paul B Anderson
Journal:  Lung       Date:  2010-04-09       Impact factor: 2.584

3.  Isolation prevalence of pulmonary non-tuberculous mycobacteria in Ontario, 1997 2003.

Authors:  Theodore K Marras; Pamela Chedore; Alicia M Ying; Frances Jamieson
Journal:  Thorax       Date:  2007-02-20       Impact factor: 9.139

Review 4.  Cavitary pulmonary disease.

Authors:  L Beth Gadkowski; Jason E Stout
Journal:  Clin Microbiol Rev       Date:  2008-04       Impact factor: 26.132

Review 5.  Epidemiology of infection by nontuberculous mycobacteria.

Authors:  J O Falkinham
Journal:  Clin Microbiol Rev       Date:  1996-04       Impact factor: 26.132

6.  Evaluation of Roche Amplicor PCR assay for Mycobacterium tuberculosis.

Authors:  W L Wobeser; M Krajden; J Conly; H Simpson; B Yim; M D'costa; M Fuksa; C Hian-Cheong; M Patterson; A Phillips; R Bannatyne; A Haddad; J L Brunton; S Krajden
Journal:  J Clin Microbiol       Date:  1996-01       Impact factor: 5.948

7.  Isolation prevalence of pulmonary nontuberculous mycobacteria in Ontario in 2007.

Authors:  Mohammed Al Houqani; Frances Jamieson; Pamela Chedore; Mauli Mehta; Kevin May; Theodore K Marras
Journal:  Can Respir J       Date:  2011 Jan-Feb       Impact factor: 2.409

8.  Pulmonary infection with opportunist mycobacteria on Merseyside 1974-1983.

Authors:  H W Clague; E H el-Ansary; C A Hopkins; C Roberts
Journal:  Postgrad Med J       Date:  1986-05       Impact factor: 2.401

9.  Mycobacterium xenopi isolation from clinical specimens in the Florence area: review of 46 cases.

Authors:  E Tortoli; M T Simonetti; C Labardi; A Lopes Pegna; E Meli; N Stanflin; S Susini
Journal:  Eur J Epidemiol       Date:  1991-11       Impact factor: 8.082

10.  Pulmonary disease caused by Mycobacterium xenopi: the first case in Korea.

Authors:  Hye Yun Park; Won-Jung Koh; O Jung Kwon; Nam Yong Lee; Young Mog Shim; Young Kil Park; Gill Han Bai; Ho-Suk Mun; Bum-Joon Kim
Journal:  Yonsei Med J       Date:  2007-10-31       Impact factor: 2.759

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.